去年，Cryoport Inc表現最佳的業務類別Life Science products的營收達到79.68M美元。Americas的營收貢獻最高，去年達到131.26M美元。最近一個季度，截至2026-06-30，Cryoport Inc表現最佳的業務類別BioLogistics solutions的營收達到22.36M美元。Americas的營收貢獻最高，達到36.89M美元。

業務

營業收入

佔比

年報

年報

單季報

Life Science products

BioLogistics solutions

BioStorage/Bioservices

Biopharmaceutical

Animal health

Reproductive medicine

FY2025

FY2024

FY2023

FY2022

FY2021

FY2019

FY2018

Life Science products

79.68M(45.23%)

74.72M(47.67%)

89.17M(19.11%)

--(--)

BioLogistics solutions

78.14M(44.35%)

67.02M(42.75%)

130.50M(27.97%)

--(--)

BioStorage/Bioservices

18.36M(10.42%)

15.03M(9.58%)

13.59M(2.91%)

--(--)

Biopharmaceutical

--(--)

192.58M(41.28%)

193.88M(81.71%)

180.20M(80.95%)

27.00M(87.35%)

16.48M(83.95%)

Animal health

--(--)

30.38M(6.51%)

33.47M(14.10%)

33.35M(14.98%)

996.00K(3.22%)

976.00K(4.97%)

Reproductive medicine

--(--)

10.29M(2.21%)

9.93M(4.19%)

9.05M(4.07%)

2.91M(9.43%)

2.17M(11.07%)

地區

營業收入

佔比

年報

年報

單季報

Americas

Europe & Middle East & Africa (EMEA)

Asia Pacific

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Americas

131.26M(74.50%)

113.55M(72.43%)

127.21M(54.54%)

128.21M(54.03%)

120.27M(54.03%)

49.55M(62.97%)

28.80M(84.85%)

17.88M(91.09%)

Europe & Middle East & Africa (EMEA)

25.13M(14.27%)

27.02M(17.24%)

60.88M(26.10%)

42.16M(17.77%)

59.33M(26.65%)

20.32M(25.82%)

4.52M(13.33%)

1.36M(6.96%)

Asia Pacific

19.78M(11.23%)

16.20M(10.33%)

45.16M(19.36%)

66.91M(28.20%)

43.00M(19.32%)

8.82M(11.21%)

618.00K(1.82%)

384.00K(1.96%)